TONGRENTANGCM

03613

5.4650.36% ( -0.020 )

Delay Closed: Nov 13, 16:08:17

Current ValuationThe current P/E ratio is 12.69, below the reasonable range, cheaper than 97.78% of the time in the past 5 years, and the industry ranks 15/53, the industry Median 6.78.

12.69xP/E

Stock priceHK$5.47Earnings per shareHK$0.43

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.78x

010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.78x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
01093HKCSPC PHARMA	10.82x	130.39%	HK$92.53B
02196HKFOSUN PHARMA	10.68x	10.29%	HK$43.74B
02096HKSIMCERE PHARMA	15.02x	31.93%	HK$27.17B
00867HKCMS	13.89x	41.06%	HK$24.53B
01513HKLIVZON PHARMA	12.24x	17.45%	HK$22.20B
00512HKGRANDPHARMA	13.81x	45.32%	HK$15.32B
02005HKSSY GROUP	14.58x	24.61%	HK$7.40B
03613HKTONGRENTANGCM	12.69x	15.96%	HK$4.57B
01666HKTONG REN TANG	10.63x	21.20%	HK$3.75B
00719HKSHANDONG XINHUA	13.61x	--	HK$3.63B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.